Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-044365

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Pablo Lapuerta
Officer — EVP and CMO
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 8:45 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 29, 2016M1,857—A10,252D
Common StockF1Feb 29, 2016M2,500—A12,752D
Common StockF1Feb 29, 2016M2,821—A15,573D
Common StockF1Feb 29, 2016M4,550—A20,123D
Common StockFeb 29, 2016F4,357$9.07D15,766D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Feb 29, 2016M1,857D——Common Stock1,8570D
Restricted Stock Units (Phantom Stock)F1,F4—Feb 29, 2016M2,500D——Common Stock2,5002,500D
Restricted Stock Units (Phantom Stock)F1,F5—Feb 29, 2016M2,821D——Common Stock2,8215,643D
Restricted Stock Units (Phantom Stock)F1,F6—Feb 29, 2016M4,550D——Common Stock4,55013,650D

Explanation of responses